Here’s the report

Sue Sisley is one of the lead researchers on the Michigan pain study. An Arizona physician who has conducted DEA-approved marijuana studies at the Scottsdale Research Institute to treat veterans suffering from PTSD, Sisley said the pain study already has enlisted about 600 patients in Nevada and Michigan.

Patients who use cannabis for chronic pain will be asked to complete a confidential online survey on an iPad at the participating dispensaries.

If the Michigan project signs up enough people — Sisley said 3,000 participants would yield publishable results — it could render the idea of Pennsylvania’s state-sanctioned research program moot. It would show meaningful investigations into the drug could be conducted without granting special privileges to marijuana companies that enter into exclusive arrangements with Pennsylvania health-care systems.

“All medical cannabis license holders have a duty to participate in science right now and not wait for anyone else to fund that or get the Institutional Review Board approvals that they could be getting themselves,” Sisley said.

The announcement of the Michigan pain project comes in the wake of a Commonwealth Court decision this week that, on its own, has the potential of  derailing Pennsylvania’s research program.